Bains et al. analysed serum HMGB1 in 50 patients with locally advanced rectal cancer undergoing an intensified neoadjuvant protocol with 4 weeks of chemotherapy followed by 5 weeks of chemoradiotherapy, both modalities containing oxaliplatin, followed by resection [32]. This evidence concerns the gene HMGB1 and rectal cancer.